Sign inJoin waitlistJoin the waitlist

Amit Maity

Professor · Univ of Utah Sch of Med

Credentials: · · · · · · ·

History

Univ of Utah Sch of Med
Present
University of Pennsylvania Health System
Present

Radiation Oncology
Hospital of the University of Pennsylvania
1986–1990
Preliminary Internal Medicine
Mount Sinai Hospital
1985–1986
University of Pennsylvania
Boston University School of Medicine
1981–1985
Boston University
1977–1981

Research

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Nature · 2015 · 2,020 citations
PI3K/AKT/mTOR Pathway in Angiogenesis
Frontiers in Molecular Neuroscience · 2011 · 1,207 citations
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Cell · 2016 · 1,001 citations

JP
John Plastaras
24 papers
Stephen Hahn
18 papers
IP
Ima Paydar
10 papers
Andy Minn
9 papers
Elise Chong
9 papers
Keith Cengel
9 papers
Michael LaRiviere
9 papers · 2 as a resident
Christopher Wright
8 papers · 6 as a resident
Jonathan Baron
8 papers · 4 as a resident
Tara Mitchell
8 papers
Gary Kao
7 papers
James Metz
7 papers

Grants

Abramson Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $406.4K · University of Pennsylvania
1997–2025
Combination of CB101 and Radiation Therapy in Head and Neck Squamous Cell Carcinoma
National Cancer Institute · R41
PI · $250.9K · Curebiotech, Inc.
2022–2025
Radiation and Checkpoint Blockade for Cancer Immune Therapy
National Cancer Institute · P01
PI · $11.5M · University of Pennsylvania
2017–2024
Improving Radiation Response by Targeting O2 Metabolism via the PI3K/mTOR Pathway
National Cancer Institute · R01
Contact PI · $1.8M · University of Pennsylvania
2015–2022

Clinical trials

RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers
Principal investigator · Completed · Phase 1
Abramson Cancer Center at Penn Medicine
2015–2019
RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA
Principal investigator · Completed · Phase 1, Phase 2
Abramson Cancer Center at Penn Medicine
2011–2015
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Principal investigator · Completed · Phase 1, Phase 2
Abramson Cancer Center at Penn Medicine
2007–2012